Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Duration of COVID-19 mRNA Vaccine Effectiveness against Severe Disease.
Bansal D, Abdulmajeed J, Al-Shamali MHMA, Albayat SSA, Himatt SM, Cyprian FS, Chivese T, Mundodan JMA, Khogali HS, Baaboura R, Kaleeckal AH, Kandy MC, Latif AN, Al-Kuwari MG, Al-Romaihi HE, Al Khal A, Bertollini R, Al-Thani MH, Farag E, Doi SAR. Bansal D, et al. Vaccines (Basel). 2022 Jun 28;10(7):1036. doi: 10.3390/vaccines10071036. Vaccines (Basel). 2022. PMID: 35891199 Free PMC article.
Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting.
Abu-Raddad LJ, Chemaitelly H, Malek JA, Ahmed AA, Mohamoud YA, Younuskunju S, Ayoub HH, Al Kanaani Z, Al Khal A, Al Kuwari E, Butt AA, Coyle P, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Yassine HM, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Bertollini R. Abu-Raddad LJ, et al. Clin Infect Dis. 2021 Oct 5;73(7):e1830-e1840. doi: 10.1093/cid/ciaa1846. Clin Infect Dis. 2021. PMID: 33315061 Free PMC article.
Two prolonged viremic SARS-CoV-2 infections with conserved viral genome for two months.
Abu-Raddad LJ, Chemaitelly H, Malek JA, Ahmed AA, Mohamoud YA, Younuskunju S, Al Kanaani Z, Al Khal A, Al Kuwari E, Butt AA, Coyle P, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Yassine HM, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Bertollini R. Abu-Raddad LJ, et al. Infect Genet Evol. 2021 Mar;88:104684. doi: 10.1016/j.meegid.2020.104684. Epub 2020 Dec 24. Infect Genet Evol. 2021. PMID: 33352320 Free PMC article.
The impact of COVID-19 pandemic on the preventive services in Qatar.
Al-Kuwari MG, Abdulmalik MA, Al-Mudahka HR, Bakri AH, Al-Baker WA, Abushaikha SS, Kandy MC, Gibb J. Al-Kuwari MG, et al. J Public Health Res. 2021 Jan 26;10(1):1910. doi: 10.4081/jphr.2021.1910. eCollection 2021 Jan 14. J Public Health Res. 2021. PMID: 33575226 Free PMC article.
Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19.
Ayoub HH, Chemaitelly H, Seedat S, Makhoul M, Al Kanaani Z, Al Khal A, Al Kuwari E, Butt AA, Coyle P, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Rahim HA, Yassine HM, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Bertollini R, Abu Raddad LJ. Ayoub HH, et al. J Glob Health. 2021 Jan 16;11:05005. doi: 10.7189/jogh.11.05005. J Glob Health. 2021. PMID: 33643638 Free PMC article.
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic.
Abu-Raddad LJ, Chemaitelly H, Ayoub HH, Al Kanaani Z, Al Khal A, Al Kuwari E, Butt AA, Coyle P, Jeremijenko A, Kaleeckal AH, Latif AN, Owen RC, Rahim HFA, Al Abdulla SA, Al Kuwari MG, Kandy MC, Saeb H, Ahmed SNN, Al Romaihi HE, Bansal D, Dalton L, Al-Thani MH, Bertollini R. Abu-Raddad LJ, et al. Sci Rep. 2021 Mar 18;11(1):6233. doi: 10.1038/s41598-021-85428-7. Sci Rep. 2021. PMID: 33737535 Free PMC article.
Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar.
Jeremijenko A, Chemaitelly H, Ayoub HH, Alishaq M, Abou-Samra AB, Al Ajmi JAAA, Al Ansari NAA, Al Kanaani Z, Al Khal A, Al Kuwari E, Al-Mohammed A, Al Molawi NHA, Al Naomi HM, Butt AA, Coyle P, El Kahlout RA, Gillani I, Kaleeckal AH, Masoodi NA, Thomas AG, Nafady-Hego H, Latif AN, Shaik RM, Younes NBM, Rahim HFA, Yassine HM, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Bertollini R, Abu-Raddad LJ. Jeremijenko A, et al. Emerg Infect Dis. 2021 May;27(5):1343-1352. doi: 10.3201/eid2705.204365. Emerg Infect Dis. 2021. PMID: 33900174 Free PMC article.
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy.
Abu-Raddad LJ, Chemaitelly H, Coyle P, Malek JA, Ahmed AA, Mohamoud YA, Younuskunju S, Ayoub HH, Al Kanaani Z, Al Kuwari E, Butt AA, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Nasrallah GK, Yassine HM, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Al Khal A, Bertollini R. Abu-Raddad LJ, et al. EClinicalMedicine. 2021 May;35:100861. doi: 10.1016/j.eclinm.2021.100861. Epub 2021 Apr 28. EClinicalMedicine. 2021. PMID: 33937733 Free PMC article.
89 results